Ursodeoxycholic acid for liver regrowth after transplant
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether taking ursodeoxycholic acid (a bile acid pill) after a living donor liver transplant helps the new liver grow and work better. It may speed up recovery and improve liver function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a living donor liver transplant at the Institute of Liver and Biliary Sciences (ILBS).
- You are an adult (18 years or older).
- You have not taken ursodeoxycholic acid in the month before your transplant.
- You do not have a known allergy to ursodeoxycholic acid.
- Your transplant is not an emergency and uses a standard graft type (not right posterior or left lateral sections).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a medicine called pentoxifylline can help your liver grow faster after donating a large part of it. You would take the medicine before and after your donor surgery.
This study looks at how genetic differences between liver donors and recipients affect fat buildup in the new liver after transplantation. It may help doctors understand why some transplanted livers develop steatosis (fatty liver) after the surgery.
This study looks at how the donor's liver grows back after donating a part of it for a living donor liver transplant. If you have donated a part of your liver between 2004 and 2026, joining could help doctors learn more about liver healing.
This study looks at living donor liver transplant care and follows patients for about 3 years to see how they do over time. If you had (or are scheduled for) a living donor liver transplant and can be followed long-term, this trial may be able to collect your outcomes.
This trial looks at whether slowly reducing UDCA (a medication for primary biliary cholangitis) is safe and still helpful in people whose liver tests have improved. It may help some patients avoid higher doses if their disease is well controlled.
This trial tests whether a living donor liver transplant can help people with a certain type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It is for patients whose cancer has not spread and who have responded well to chemotherapy.
Hear when a new Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.